Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment

Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment

Salonee Martins, Purva Salvi, Sai Tejaswi Lavuri, Manjita Srivastava, Shalini Sakthivel, Muneesh Kumar Barman, Kailash Chand, Meenakshi Singh, Subash C. Sonkar, Prudhvilal Bhukya
Copyright: © 2021 |Pages: 47
DOI: 10.4018/978-1-7998-6530-8.ch002
OnDemand:
(Individual Chapters)
Available
$37.50
No Current Special Offers
TOTAL SAVINGS: $37.50

Abstract

With the evolution of the tissue system and division of function among differentiated cells/tissues, the property of controlled cell growth also evolved in animals. It is when this very control is lost that cancers develop. The immune system's ability to distinguish between self and non-self is central to impeding cancer progression. However, cancer cells in time can develop multiple ways of escaping immune control. Even today, cancer remains a disease of baffling complexity on account of its diverse origin and pathogenesis. Classical methods like surgery, radiation, and chemotherapy have failed to make the cut as idyllic therapy, especially considering the encumbering side-effects and high failure rate. Alternative therapeutic strategies that exploit the immune system itself have proved promising. One of these is monoclonal antibody therapy. In this chapter, the relationship between the immune system and cancer and various forms of immunotherapy are discussed in detail.
Chapter Preview
Top

Cancer And The Immune System

The immune system is indispensable in the protection of an organism against infection and trauma; from aggressors of exogenous and endogenous origin [Candeias & Gaipl., 2016].It was Rudolph Virchow who first discovered the relation between the immune system and cancer in the 1860’s [Adams et al., 2015]. In recent years it has become evident that both, the innate and adaptive immune system play a role in not only the curbing, but also as the promotion of cancer development.

The complex dynamic mechanism of ‘immunoediting’ maintains the balance between immune surveillance and cancer progression. It is principally composed of 3 phases that aid the cancer elimination, dormancy and escape respectively; namely, elimination, equilibrium, and escape [Schreiber et al., 2011].

Complete Chapter List

Search this Book:
Reset